Bit Capital Gmb H Denali Therapeutics Inc. Transaction History
Bit Capital Gmb H
- $1.26 Trillion
- Q4 2024
A detailed history of Bit Capital Gmb H transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Bit Capital Gmb H holds 21,011 shares of DNLI stock, worth $432,406. This represents 0.03% of its overall portfolio holdings.
Number of Shares
21,011
Previous 29,762
29.4%
Holding current value
$432,406
Previous $867 Million
50.61%
% of portfolio
0.03%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding DNLI
# of Institutions
236Shares Held
120MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$271 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$253 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$247 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$203 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$163 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.76B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...